Alumni raised $1.45B in 2022 - Download Free Report Now

Vapotherm (NYSE:VAPO)

Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Vapotherm (NYSE:VAPO) plus 5521 other startups.

Start Free 7 Day Trial Now

Learn More About Vapotherm (NYSE:VAPO)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With